mifepristone has been researched along with Chlamydia Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gissler, M; Heikinheimo, O; Hemminki, E; Mentula, M; Niinimäki, M; Suhonen, S | 1 |
| Bokström, H; Norström, A; Wiqvist, N | 1 |
2 other study(ies) available for mifepristone and Chlamydia Infections
| Article | Year |
|---|---|
Comparison of rates of adverse events in adolescent and adult women undergoing medical abortion: population register based study.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Incomplete; Abortion, Induced; Adolescent; Adult; Age Distribution; Chlamydia Infections; Female; Finland; Hemorrhage; Humans; Incidence; Mifepristone; Misoprostol; Pregnancy; Pregnancy Complications, Cardiovascular; Registries; Risk Factors; Young Adult | 2011 |
Cervical mucus concentration of prostaglandins E2 and F2 alpha after pretreatment with mifepristone in the first trimester of pregnancy.
Topics: Abortion, Legal; Adult; Cervix Mucus; Cervix Uteri; Chlamydia Infections; Chlamydia trachomatis; Dilatation and Curettage; Dinoprost; Dinoprostone; Female; Gestational Age; Humans; Mifepristone; Nausea; Pregnancy; Pregnancy Trimester, First; Time Factors; Vaginosis, Bacterial | 1995 |